Latest Technology News

Enlitic has signed a binding MoU with GE HealthCare to deliver up to A$50 million in migration services over five years, contingent on a A$10 million equity raise that the company has now initiated.

Kinatico (ASX:KYP) has upgraded its SaaS revenue forecast for the second half of FY25 to $8.3 million, driven by strong demand for its compliance and credential validation software. The company’s recent sales hires and April launch of Kinatico Compliance underpin this optimistic outlook.

Bio-Gene Technology Limited is progressing its development of two novel insecticidal compounds, Qcide and Flavocide, targeting major global markets with strong commercial validation and significant US Department of Defense funding.

Proteomics International Laboratories Ltd is raising up to $5.5 million through a $4 million placement and a $1 million Share Purchase Plan at $0.37 per share, offering shareholders a discounted entry and free attaching options.

Excite Technology Services has raised $2.8 million through a placement to accelerate growth in cybersecurity services and training, including investment in its flagship Nangu Tactical Centre.

Hazer Group has entered a binding six-year strategic alliance with global engineering leader KBR to exclusively market and license its methane pyrolysis technology, targeting the ammonia and methanol sectors. This partnership aims to accelerate commercialisation, expand global reach, and materially de-risk Hazer’s business plan.

Critica Limited has secured drilling approvals and government funding to explore high-grade heavy rare earth elements at its Aurora and Juno satellite prospects near the flagship Jupiter deposit in Western Australia.

Synertec Corporation reports a 7.7% revenue increase in FY25 Q3, highlights robust Powerhouse technology performance during extreme weather, and secures a US patent for its LNG Custody Transfer System.

DTI Group Limited has announced a fully underwritten pro-rata entitlement offer to raise approximately $2.69 million, primarily aimed at repaying a $1.25 million loan from major shareholder Finico Pty Ltd. The offer opens on 13 May and closes on 10 June 2025, with new shares priced at $0.006 each.

4DMedical has landed a significant commercial contract with Intermountain Health to deploy its FDA-cleared Pulmonary Hypertension Analysis (PHA™) product, marking a key milestone in its U.S. expansion through a strategic Microsoft-backed partnership.

ABx Group has discovered a new rare earth element province 52 km east of its Deep Leads resource in northern Tasmania, revealing exceptionally high grades of terbium and dysprosium critical for advanced technologies. This discovery aligns with shifting global supply dynamics amid US incentives and Chinese export restrictions.

Bio-Gene Technology Limited has raised $2.1 million through a placement and launched a Share Purchase Plan to fund critical safety studies for its flagship insecticide Flavocide®, alongside development of Qcide and strategic initiatives.